Vidacare » Corporation » Milestones
- 2010 OnControl™ Bone Access System is commercially available
- 2010 American Association of Critical-Care Nurses (AACN ) announces support
of INS position paper endorsing role of IO
- 2009 Vidacare B. V. headquarters established outside of Amsterdam
- 2009 FDA clears EZ-IO for use in “medically necessary” situations
- 2009 Vidacare relocates corporate headquarters to a 17,000 square foot space
in North San Antonio (Shavano Park)
- 2009 OnControl Bone Marrow System is commercially available
- 2009 Emergency Nurses Association (ENA ) announces support of IN S position
paper endorsing role of IO
- 2009 Infusion Nurses Society (INS) endorses intraosseous access as alternative
to traditional IVs, and supports its use by registered nurses
- 2008 FDA 510(k) clearance of OnControl™ Bone Access System for use
in vertebroplasty
- 2008 Vidacare releases the 45mm EZ-IO needle set for patients requiring a
longer needle for vascular access
- 2007 Vidacare B. V. incorporated for international operations
- 2007 FDA 510(k) clearance of OnControl Bone Marrow System for bone marrow
biopsy
- 2007 FDA 510(k) clearance of EZ-IO insertion in distal tibia (ankle) for
vascular access
- 2007 E Z-IO product adapted for military use in sternal site
- 2007 FDA 510(k) clearance of EZ-IO sternal device
- 2007 National Association of EM S Physicians endorses intraosseous access
as alternative to traditional IV
- 2006 Vidacare opens European office in United Kingdom
- 2006 FDA 510(k) clearance of OnControl™ Bone Marrow System for bone
marrow aspiration
- 2006 International Liaison Committee on Resuscitation (ILCOR) revises its
pediatric guidelines to recommend IO as first alternative to peripheral IVs
- 2006 European Resuscitation Council (ERC) revises its guidelines to recommend
IO as first alternative to peripheral IVs
- 2005 FDA 510(k) clearance of EZ-IO insertion in proximal humerus (shoulder)
for vascular access
- 2005 American Heart Association revises its Advanced Cardiac Life Support
(AC LS) guidelines to recommend IO as first alternative to peripheral intravenous
lines (IVs)
- 2005 FDA 510(k) clearance of EZ-IO needle set for pediatric use
- 2004 FDA 510(k) clearance of EZ-IO ® Intraosseous Infusion System’s
power driver and needle set for use in adults
- 2001 Vidacare Corporation is established in San Antonio, Texas
- 2000 D r. Larry Miller and research team work with The University of Texas
Health Science Center at San Antonio to develop Vidacare’s patented technology
platform
